Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
Clinical trial NCT03050814 · TERMINATED
Trial details
- NCT number
- NCT03050814
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2021-08-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.